AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,818,000 | +62.8% | 114,980 | +58.9% | 1.04% | +80.3% |
| Q2 2016 | $1,731,000 | -72.1% | 72,380 | -72.7% | 0.58% | -71.2% |
| Q1 2016 | $6,205,000 | +84.8% | 265,180 | +138.5% | 2.01% | +79.0% |
| Q4 2015 | $3,357,000 | -10.2% | 111,180 | +18.2% | 1.12% | -10.0% |
| Q3 2015 | $3,739,000 | +577.4% | 94,100 | +831.7% | 1.25% | +585.7% |
| Q1 2015 | $552,000 | – | 10,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |